University of Oxford

Health
AstraZeneca Covid-19 vaccine trial resumes after pausing over safety concerns
AstraZeneca Covid-19 vaccine trial resumes after pausing over safety concerns
Credit: AstraZeneca

Clinical trials for the AstraZeneca Covid-19 vaccine have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.

The company paused trials earlier this week after a possible adverse severe reaction in one participant.

In a statement, the company said it "will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic."

Regional News • Americas
Argentina, Mexico to produce AstraZeneca Covid-19 vaccine
Ginés González García and Alberto Fernández
Ginés González García and Alberto Fernández Credit: Argentina.gob.ar (Public Domain)

Argentinean President Alberto Fernández announced Wednesday that the private laboratory AstraZeneca would begin to produce in Argentina and Mexico a vaccine against the coronavirus that is developed in conjunction with the University of Oxford.

The president explained the goal is "to produce between 150 and 250 million vaccines for all of Latin America -except for Brazil- that will be available by the first half of 2021."

Fernández stated, "Latin American production will be in charge of Argentina and Mexico, and that will allow timely and sufficient access to potential vaccine for all countries in the region."

Health
AstraZeneca to distribute 2 billion doses of Covid-19 vaccine at no profit
AstraZeneca Manufacturing
AstraZeneca Manufacturing Credit: AstraZeneca

AstraZeneca, which will produce the promising Covid-19 vaccine developed by the University of Oxford, announced Tuesday that it will distribute 2 billion doses at cost.

The announcement was made by Menelas Pangalos, executive vice president of the company, in a virtual meeting before an investigative subcommittee of the Energy and Commerce Committee of the US Congress.

Health
Study: Oxford Covid-19 vaccine triggers immune response

Researchers from Oxford have published new results from their ongoing trails of a possible Covid-19 vaccine. During the last trial that involved 1,077 people, it showed that the experimental vaccine not only leads the patients to develop antibodies but also T-cells that are able to fight the virus.

The United Kingdom has already ordered 100 million doses of the vaccine. Further trials are still underway to determine if patients develop a long term immunitiy.

Health
Oxford researchers claim that their Covid-19 vaccine could give long term immunity
Oxford researchers claim that their Covid-19 vaccine could give long term immunity
Credit: unsplash.com / National Cancer Institute

Professor Sarah Gilbert has announced that the Covid-19 vaccine that is currently in trials at Oxford could provide long term immunity and has been found to generate three times higher levels of antibodies than in patients who recovered from Covid-19. Similar vaccines that use the same type of technology have shown that people show strong immune responses even after a longer time. Gilbert has said that they are optimistic as earlier studies have shown promising results.

Regional News • Americas • Brazil
Brazil to start production of experimental Covid-19 vaccine
Brazil to start production of experimental Covid-19 vaccine
Credit: Centers for Disease Control and Prevention (Creative Commons CC0 Waiver)

The Brazilian government has announced on Saturday that it will start producing an experimental Covid-19 vaccine locally. The government has signed an agreement worth $127 million with AstraZeneca who developed the experimental vaccine. According to the World Health Organization the vaccine is considered the world's leading candidate which has been developed by researchers at Oxford University in the United Kingdom. Human trials are still undergoing and final proof of the effect against Covid-19 is still pending.

Regional News • Americas • Brazil
Brazil is close to a deal to produce Oxford Covid-19 vaccine
Brazil is close to a deal to produce Oxford Covid-19 vaccine
Credit: Centers for Disease Control and Prevention (Creative Commons CC0 Waiver)

Brazilian interim Health Minister Eduardo Pazuello said Brazil is close to signing a contract to produce a trial vaccine developed by the Oxford University and supported by AstraZeneca.

The country started human clinical trials for the potential vaccine this weekend with 3,000 people in São Paulo and Rio de Janeiro, becoming the first country outside the United Kingdom to test the vaccine.

Oxford researchers expect to launch the vaccine by year-end.

Arts, Entertainment, Culture • Celebrities & Public Figures
Malala Yousafzai graduates from Oxford University
Pakistani activist for female education Malala Yousafzai with Prime Minister of Japan Shinzō Abe in 2019
Pakistani activist for female education Malala Yousafzai with Prime Minister of Japan Shinzō Abe in 2019 Credit: 内閣官房内閣広報室 / CC BY (Creative Commons Attribution 4.0)

Nobel Prize laureate Malala Yousafzai has graduated from the University of Oxford with a degree in philosophy, politics and economics. In 2012, Yousafzai was shot in the head by a Taliban gunman due to her activism for female education.

In a Tweet, Yousafzai shared images of her graduation celebration and wrote: "Hard to express my joy and gratitude right now as I completed my Philosophy, Politics and Economics degree at Oxford. I don’t know what’s ahead. For now, it will be Netflix, reading and sleep."

Health
Covid-19 breakthrough: Dexamethasone proves first life-saving drug
Dexamethasone
Dexamethasone Credit: melvil (Creative Commons Attribution ShareAlike 4.0)

Researchers in the United Kingdom said they have the first evidence that a drug can improve Covid-19 survival.

The effect of dexamethasone was most striking among critically ill patients on ventilators. Those who were receiving oxygen therapy but were not on ventilators also saw improvement: their risk of dying was reduced by 20%.

Shortly after the results were released, the UK government announced that it had immediately authorised use of dexamethasone for patients hospitalised with Covid-19 who required oxygen, including those on ventilators.

Regional News • Europe • United Kingdom
“Don’t be fooled, Rhodes was a racist” – Protestors Demand Removal of Oxford Statue

In 2015 students at Oxford University had first demanded the removal of the statue of Cecil Rhodes, a leading figure in British imperialism. Now, five years later, hundreds of students and residents have gathered at Oriel College at the University of Oxford, once again, to demand the removal of the statue.

Oxford student and one of the protest's organisers told the Independent that many of their demands had fallen on deaf ears but that students would continue to “object to the institutional practises that are symbolised by objectionable iconography such as that of Cecil Rhodes”.

Science • Medicine
University of Oxford Plans to Roll Out Covid-19 Vaccine by September if Trials Successfull
University of Oxford
University of Oxford Credit: unsplash.com/Tetiana SHYSHKINA

In his Sunday briefing, Business Secretary Alok Sharma said clinical trials for the Covid-19 vaccine by the University of Oxford were progressing well. The trial is currently in phase one and all participants have received their doses. Oxford has received over £47 million by the government so far and Sharma announced another £84 million in new funding.

Sharma added: "This means that if the vaccine is successful AstraZeneca (a British-Swedish multinational pharmaceutical and biopharmaceutical company) will work to make 30 million doses available by September for the UK as part of an agreement for over 100 million doses in total."